M&A - ACUTA CAPITAL PARTNERS, LLC

Form Type: SCHEDULE 13D/A

Filing Date: 2025-01-24

Corporate Action: Acquisition

Type: Update

Accession Number: 000093583625000082

Filing Summary: Acuta Capital Partners, LLC and its affiliates are reporting their holdings and strategic intentions regarding Aadi Bioscience, Inc. The report indicates that Mr. Anupam Dalal, a member of the issuer's board, is among the reporting persons. Acuta Capital utilized $23,999,989.95 for common stock purchases, believing the stock was undervalued. Significant transactions include a Subscription Agreement for 1,561,000 shares at $2.40 per share, pending certain conditions. Furthermore, Acuta Capital has involved itself in a PIPE Financing where shares are being sold to multiple investors and entered into a Stock Purchase Agreement for the acquisition of Aadi Subsidiary, Inc. for $100,000,000 with associated voting agreements to support these actions at stockholder meetings. The reporting parties hold a total of 1,849,402 shares or 7.5% of Aadi's common stock, with intentions open for future investment actions depending on market conditions.

Document Link: View Document